Cited by 32Complement system in diseasesRenal Diseases and GlomerulopathiesRetinal Diseases and Treatments

Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases

Open access
Recalde, Sergio, Tortajada, Agustin, Subias, Marta, Anter, Jaouad, Blasco, Miquel, Maranta, Ramona, Coco, Rosa, Pinto, Sheila +3 more·2016·Journal of the American Society of Nephrology

Abstract

The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa , a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.

Integrity signals

Registry

Crossref · 10.1681/asn.2015050580

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with genetic abnormalities in the complement system tend to only develop overt disease in one organ (such as AMD, C3 glomerulopathy, or atypical haemolytic uraemic syndrome), even in the presence of rare, pathogenic variants or haploinsufficiency of FH and FI.

    “patients with genetic abnormalities in the complement system tend to only develop overt disease in one organ (such as AMD, C3 glomerulopathy, or atypical haemolytic uraemic syndrome), even in the presence of rare, pathogenic variants or haploinsufficiency of FH and FI [81,220,221,222,223].”

The citation lists haven’t been fetched yet

References 36 · Cited by 32

Authors
Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., Coco, R., Pinto, S., Noris, M., García-Layana, A., & Rodríguez de Córdoba, S.
Affiliations
  • Clinica Universidad de Navarra (ES)
  • Department of Cellular and Molecular Medicine, Center for Biological Research and Center for Biomedical Network Research on Rare Diseases, Madrid, Spain;
  • Centre for Biomedical Network Research on Rare Diseases (ES)
  • Hospital Clínic de Barcelona (ES)
  • Mario Negri Institute for Pharmacological Research (IT)
  • Universidad de Valladolid (ES)
  • Department of Ophthalmology, University Clinic of Navarra, Pamplona, Navarra, Spain;
Corresponding author
Recalde, Sergio
Venue
Journal of the American Society of Nephrology
Published
2015-09-16
Volume
27
Issue
5
Pages
1305-1311
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W1928260253
Cited by
32
References
36
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 7 · 2017: 5 · 2016: 5
FWCI
2.79
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
Akershus Universitetssykehus
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
complement factor H, atypical hemolytic uremic syndrome, age-related macular degeneration, C3 glomerulopathy, factor H deficiency, complement system, disease phenotypes, genetic risk factors, kidney disease, eye diseases
MeSH terms
Complement C3, Female, Humans, Kidney Diseases, Kidney Glomerulus, Macular Degeneration, Male, Middle Aged, Mutation, Pedigree, Complement Factor H, Atypical Hemolytic Uremic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review